December 17th 2024
Measuring end points such as molecular response, cytokines, and histomorphometry may show a greater range of benefits.
Blood Shortages Impacting Myelofibrosis Care
December 22nd 2023Experts discuss the ramifications of red blood cell transfusion shortages on myelofibrosis patient management and delve into the scarcity’s effects, patient prioritization, and the struggle for consistency in care amid supply challenges.
Watch
Myelofibrosis Care: Pharmacist Role and Treatment Challenges
December 20th 2023Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, and a panel of pharmacists explore pharmacist roles in myelofibrosis care, treatment challenges, patient outcomes, and pharmacist responsibilities within interdisciplinary teams.
Watch
Lead Investigator Provides Insight Into FDA Approval of Momelotinib for Myelofibrosis
September 29th 2023Ruben A. Mesa, MD, FACP, discusses the results of the SIMPLIFY-1 and MOMENTUM trials and how the data led to the approval of momelotinib to treat intermediate or high-risk myelofibrosis in adult patients with anemia.
Watch
Expert Panel Discusses Advocacy, Education for Patients With Myeloproliferative Neoplasms
July 14th 2023Despite a slew of barriers with patient management, pharmacists have the training and resources to advocate for better patient care and help patients with hematologic myeloproliferative neoplasms advocate for themselves.
Read More